BMO Capital Maintains Market Perform on Ingevity, Lowers Price Target to $40
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst John McNulty has maintained a Market Perform rating on Ingevity (NYSE:NGVT) while lowering the price target from $42 to $40.
September 30, 2024 | 3:37 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
BMO Capital has maintained its Market Perform rating on Ingevity but has lowered the price target from $42 to $40, indicating a slightly less optimistic outlook.
The lowering of the price target by BMO Capital suggests a slightly less optimistic view on Ingevity's short-term performance, which could lead to a negative impact on the stock price. The Market Perform rating indicates a neutral stance, but the reduced price target may influence investor sentiment negatively.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100